Evidence map›Paper›PMID 29959430›Full record

ReviewNature reviews. Endocrinology2018

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Giovanna Mantovani, Murat Bastepe, David Monk, Luisa de Sanctis, Susanne Thiele, Alessia Usardi, S Faisal Ahmed, Roberto Bufo, Timothée Choplin, Gianpaolo De Filippo and 36 more

2 registry-linked trialsOpen access · hybridAbstract readReviewConsensus Statement
In one paragraph

Review in Nature reviews. Endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 179 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed, 2 pooled it
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00209235 naactive not recruitingnot on this map

Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy

TypeinterventionalSponsorConnecticut Children's Medical CenterRan2003 to 2030Enrolled600ConditionsPseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy, PseudopseudohypoparathyroidismArmsNeurocognitive and psychosocial testing
NCT04569604 completednot on this mapstarted 2019, after this paper: background citation

Impaired Quality of Life and Cognitive Function in Patients With Hypoparathyroidism Might be Explained by Disturbed Capillary Flow Patterns in the Brain

TypeobservationalSponsorUniversity of AarhusRan2019 to 2021Enrolled64ConditionsHypoparathyroidism, Pseudo HypoparathyroidismArmsMRI scans, Neuro cognitive tests, Questionnaires on Quality of Life, Blood samples, 24 hr urine samples
3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 2 syntheses or guidelines pooled it, 329 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Severe infantile obesity with a maternalClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 20 institutions in 13 countries.

Giovanna MantovaniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Murat BastepeEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
David MonkImprinting and Cancer Group, Cancer Epigenetic and Biology Program (PEBC), Institut d'Investigació Biomedica de Bellvitge (IDIBELL), Barcelona, Spain.
Luisa de SanctisPediatric Endocrinology Unit, Department of Public Health and Pediatric Sciences, University of Torino, Turin, Italy.
Susanne ThieleDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Lübeck, Lübeck, Germany.
Alessia UsardiAPHP, Reference Center for Rare Disorders of Calcium and Phosphate Metabolism, Platform of Expertise Paris-Sud for Rare Diseases and Filière OSCAR, Bicêtre Paris Sud Hospital (HUPS), Le Kremlin-Bicêtre, France.
S Faisal AhmedDevelopmental Endocrinology Research Group, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0003-0689-5549
Roberto BufoIPOHA, Italian Progressive Osseous Heteroplasia Association, Cerignola, Foggia, Italy.
Timothée ChoplinK20, French PHP and related disorders patient association, Jouars Pontchartrain, France.
Gianpaolo De FilippoAPHP, Department of medicine for adolescents, Bicêtre Paris Sud Hospital (HUPS), Le Kremlin-Bicêtre, France.
Guillemette DevernoisK20, French PHP and related disorders patient association, Jouars Pontchartrain, France.
Thomas EggermannInstitute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Francesca M ElliFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-4643-3843
Kathleen FresonDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, Gasthuisberg, University of Leuven, Leuven, Belgium.
Aurora García RamirezAEPHP, Spanish PHP and related disorders patient association, Huércal-Overa, Almería, Spain.
Emily L Germain-LeeAlbright Center & Center for Rare Bone Disorders, Division of Pediatric Endocrinology & Diabetes, Connecticut Children's Medical Center, Farmington, CT, USA.
Lionel GroussinAPHP, Department of Endocrinology, Cochin Hospital (HUPC), Paris, France.
Neveen HamdyDepartment of Medicine, Division of Endocrinology and Centre for Bone Quality, Leiden University Medical Center, Leiden, Netherlands.
Patrick HannaINSERM U1169, Bicêtre Paris Sud, Paris Sud - Paris Saclay University, Le Kremlin-Bicêtre, France.
Olaf HiortDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Lübeck, Lübeck, Germany.
Harald JüppnerEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Peter KamenickýAPHP, Reference Center for Rare Disorders of Calcium and Phosphate Metabolism, Platform of Expertise Paris-Sud for Rare Diseases and Filière OSCAR, Bicêtre Paris Sud Hospital (HUPS), Le Kremlin-Bicêtre, France.
Nina KnightUK acrodysostosis patients' group, London, UK.
Marie-Laure KottlerDepartment of Genetics, Reference Centre for Rare Disorders of Calcium and Phosphate Metabolism, Caen University Hospital, Caen, France.
Elvire Le NorcyUniversity of Paris Descartes, Sorbonne Paris Cité, Paris, France.
Beatriz LecumberriDepartment of Endocrinology and Nutrition, La Paz University Hospital, Madrid, Spain.
Michael A LevineDivision of Endocrinology and Diabetes and Center for Bone Health, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Outi MäkitieChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Regina MartinOsteometabolic Disorders Unit, Hormone and Molecular Genetics Laboratory (LIM/42), Endocrinology Division, Hospital das Clínicas HCFMUSP, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.
Gabriel Ángel Martos-MorenoDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús, CIBERobn, ISCIII, Madrid, Spain.
Masanori MinagawaDivision of Endocrinology, Chiba Children's Hospital, Chiba, Japan.
Philip MurrayDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0002-1480-1576
Arrate PeredaMolecular (Epi)Genetics Laboratory, BioAraba National Health Institute, Hospital Universitario Araba-Txagorritxu, Vitoria-Gasteiz, Alava, Spain.
Robert PignoloDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.
Lars RejnmarkDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-2152-4247
Rebecca RodadoAEPHP, Spanish PHP and related disorders patient association, Huércal-Overa, Almería, Spain.
Anya RothenbuhlerAPHP, Reference Center for Rare Disorders of Calcium and Phosphate Metabolism, Platform of Expertise Paris-Sud for Rare Diseases and Filière OSCAR, Bicêtre Paris Sud Hospital (HUPS), Le Kremlin-Bicêtre, France.
Vrinda SaraffDepartment of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK.
Ashley H ShoemakerPediatric Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, TN, USA.
Eileen M ShoreDepartments of Orthopaedic Surgery and Genetics, Center for Research in FOP and Related Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Caroline SilveAPHP, Service de Biochimie et Génétique Moléculaires, Hôpital Cochin, Paris, France.
Serap TuranDepartment of Pediatrics, Division of Endocrinology and Diabetes, Marmara University, Istanbul, Turkey.
Philip WoodsUK acrodysostosis patients' group, London, UK.
M Carola ZillikensDepartment of Internal Medicine, Bone Center Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Guiomar Perez de NanclaresMolecular (Epi)Genetics Laboratory, BioAraba National Health Institute, Hospital Universitario Araba-Txagorritxu, Vitoria-Gasteiz, Alava, Spain. gnanclares@osakidetza.eus.ORCID http://orcid.org/0000-0002-2424-5294
Agnès LinglartAPHP, Reference Center for Rare Disorders of Calcium and Phosphate Metabolism, Platform of Expertise Paris-Sud for Rare Diseases and Filière OSCAR, Bicêtre Paris Sud Hospital (HUPS), Le Kremlin-Bicêtre, France. agnes.linglart@aphp.fr.
Assistance Publique – Hôpitaux de Paris · FRDélégation Paris 5 · FRHarvard University · USHospital Txagorritxu · ESThe Patients Association · GBUniversité Paris-Sud · FRUniversity of Lübeck · DEUniversity of Milan · ITAarhus University Hospital · DKAssociazione Italiana Ematologia Oncologia Pediatrica · ITBirmingham Children's Hospital · GBChiba Hospital · JPChildren's Hospital of Philadelphia · USErasmus MC · NLHôpital Cochin · FRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital Universitario La Paz · ESInserm · FRInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Salud Carlos III · ES

Funding

Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1R01DK112955 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Michael A. Levine, David R Weber · 2017 to 2026
$5.1M
XLas Relative to Gsa in Bone and Mineral Ion MetabolismR01DK073911 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BASTEPE, MURAT · 2007 to 2020
$4.9M
Early Onset Obesity and Cognitive Impairment in PseudohypoparathyroidismK23DK101689 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHOEMAKER, ASHLEY HALL · 2014 to 2018
$778k
Investigation of Hypercalciuria as a Cause of Impaired Bone Mineral Accrual in Type 1 DiabetesK23DK114477 · NIDDK · UNIVERSITY OF ROCHESTER · PI WEBER, DAVID R · 2017 to 2019
$573k
Medical Research Council MR/N003403/1NIDDK NIH HHS K23 DK101689NIDDK NIH HHS K23 DK114477NIDDK NIH HHS R01 DK073911NIDDK NIH HHS R01 DK112955
6 · The paper itself

Abstract

This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset obesity and ectopic ossifications, as well as endocrine defects that often include resistance to parathyroid hormone (PTH) and TSH. The presentation and severity of PHP and its related disorders vary between affected individuals with considerable clinical and molecular overlap between the different types. A specific diagnosis is often delayed owing to lack of recognition of the syndrome and associated features. The participants in this Consensus Statement agreed that the diagnosis of PHP should be based on major criteria, including resistance to PTH, ectopic ossifications, brachydactyly and early-onset obesity. The clinical and laboratory diagnosis should be confirmed by a molecular genetic analysis. Patients should be screened at diagnosis and during follow-up for specific features, such as PTH resistance, TSH resistance, growth hormone deficiency, hypogonadism, skeletal deformities, oral health, weight gain, glucose intolerance or type 2 diabetes mellitus, and hypertension, as well as subcutaneous and/or deeper ectopic ossifications and neurocognitive impairment. Overall, a coordinated and multidisciplinary approach from infancy through adulthood, including a transition programme, should help us to improve the care of patients affected by these disorders.

Indexed as

Delayed DiagnosisDrug ResistanceFemaleGenetic Predisposition to DiseaseHumansInfant, NewbornMaleNeonatal ScreeningParathyroid HormonePrognosisProgram DevelopmentPseudohypoparathyroidismRisk AssessmentParathyroid Hormone

Identifiers

PMID29959430
PMCPMC6541219
OpenAlexW2811181045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.